AstraZeneca COVID Drug Has Monoclonal Antibodies to Prevent Infection, Gets FDA Authorization
AstraZeneca's COVID Drug has Monoclonal Antibodies that prevent infection for immunocompromised people, now an emergency authorized by the FDA.
Source: techtimes.com